During the past decade, Summit Clinical Research, LLC conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 4 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 4 clinical trials were completed. i.e. 80% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Summit Clinical Research, LLC" are "Crohn Disease" (3 trials), "Colorectal Cancer" (2 trials), "Dermatitis, Atopic" (2 trials), "Alopecia Areata" (1 trials) and "Atopic Dermatitis" (1 trials). Many other conditions were trialed in "Summit Clinical Research, LLC" in a lesser frequency.

Most popular intervention types in "Summit Clinical Research, LLC" are "Drug" (8 trials), "Other" (3 trials), "Diagnostic Test" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Ozanimod" (3 trials), "PF-06700841" (2 trials), "Vehicle (Placebo)" (2 trials) and "Abrocitinib 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Summit Clinical Research, LLC" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Summit Clinical Research, LLC". undefined are not yet recruiting, 3 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Summit Clinical Research, LLC, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Summit Clinical Research, LLC, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".